We work with FDA-registered, U.S.-based compounding pharmacies that comply with USP 797 and 795 standards
There are no controlled trials of microinfusion-delivered peptides and growth factors in pregnancy, and the regulatory and clinical default in the absence of safety data is non-intervention
Although not documented in the BPC-157 literature specifically, any injectable peptide overdose should prompt emergency assessment if the patient develops chest pain, difficulty breathing, significant hypotension (systolic BP sterile compounding standards, and provides certificates of analysis (COAs) with third-party potency and purity testing 15
Kumaresan N, Sinthiya MMA, Praveen Kumar M et al (2020) Investigation on the g-C3N4 encapsulated ZnO nanorods heterojunction coupled with GO for effective photocatalytic activity under visible light irradiation
The honest answer is that BPC-157 is worth it for some patients and not for others, and the deciding factor is rarely the price